| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals, Inc. (AMLX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. AMLX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.32M | $51.99M | - | |
| CEO | 3.32M | $51.99M | - | |
| Dir | 812.9K | $12.74M | - | |
| CFO | 177.1K | $2.78M | - | |
| Other | 175.8K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2023 | Morningside Venture Investments Ltd93 | 10% Owner | Sell | 220,714 | $33.68 | $7,433,458.52 | -1.0% | -24.8% | -90.6% | |
| Mar 2, 2023 | Morningside Venture Investments Ltd93 | 10% Owner | Sell | 50,000 | $33.75 | $1,687,500.00 | -0.7% | -26.6% | -44.4% | |
| Feb 24, 2023 | Mazzariello Gina53 | Chief Legal Officer | Sell | 3,586 | $34.49 | $123,671.82 | -8.7% | -23.8% | -48.9% | |
| Feb 23, 2023 | Morningside Venture Investments Ltd93 | 10% Owner | Sell | 100,000 | $35.78 | $3,578,102.71 | -0.3% | -24.1% | -50.1% | |
| Feb 22, 2023 | Morningside Venture Investments Ltd93 | 10% Owner | Sell | 50,000 | $34.73 | $1,736,351.68 | -0.3% | -24.2% | -48.7% | |
| Jan 6, 2023 | Olinger Margaret | Chief Commercial Officer | Sell | 2,403 | $36.30 | $87,225.05 | -0.6% | -21.4% | -54.5% | |
| Jan 6, 2023 | Yeramian Patrick D84 | Chief Medical Officer | Sell | 2,034 | $36.30 | $73,831.01 | -0.5% | -21.4% | -54.5% | |
| Jan 6, 2023 | Cohen Joshua B60 | Co-chief Executive Officer | Sell | 5,968 | $36.30 | $216,629.35 | -0.1% | -21.4% | -54.5% | |
| Jan 6, 2023 | Frates James M83 | Chief Financial Officer | Sell | 2,658 | $36.30 | $96,481.25 | -3.7% | -21.4% | -54.5% | |
| Jan 6, 2023 | Klee Justin B.60 | Co-chief Executive Officer | Sell | 5,968 | $36.30 | $216,629.35 | -0.1% | -21.4% | -54.5% |